Peri-Transplant Administration of Ruxolitinib (rux) in Patients with Myelofibrosis (MF) is Safe and Effective. A Pilot StudyHaris Ali,David S. Snyder, Ni-Chun Tsia,Timothy Synold,Sally Mokhtari,Joycelynne Palmer,Syed Rahmanuddin,Amandeep Salhotra,Vinod Pullarkat,Ji-Lian Cai,Stephen J. Forman,Matthew Mei,Ryotaro NakamuraTransplantation and Cellular Therapy（2021）City Of Hope National Medical Center被引用0|浏览6关键词Ruxolitinib Therapy,Myelofibrosis上传PDF原文链接分享引用加入学术空间AI Read Science数据免责声明页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cnChat Paper正在生成论文摘要
原文链接
分享
引用
